Assessment of 99tcm-tetrofosmin lung uptake a modified method to avoid the contribution from high chest wall activity

Nuclear Medicine Communications

Volumn 19, Issue 9, 1998, Pages 859-866

  Heiba, S I ^a   Ziada, G ^a   Higazy, E ^a   Saleh, M ^a   Elgazzar, A H ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TETROFOSMIN TC 99M; THALLIUM 201; DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE; THALLIUM;

ADULT; ARTICLE; DRUG UPTAKE; EXERCISE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG SCINTISCANNING; MALE; MUSCLE CONTRACTION; NORMAL HUMAN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX WALL; BLOOD PRESSURE; COMPARATIVE STUDY; EXERCISE TEST; HEART; HEART RATE; HEMODYNAMICS; LUNG; MIDDLE AGED; PHYSIOLOGY; REFERENCE VALUE; SCINTISCANNING; TISSUE DISTRIBUTION; TRANSPORT AT THE CELLULAR LEVEL;

ADULT; BIOLOGICAL TRANSPORT; BLOOD PRESSURE; EXERCISE TEST; HEART; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; LUNG; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; REFERENCE VALUES; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031593847     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199809000-00006     Document Type: Article

References (29)

1. Boucher G, Zir L, Beller G et al. Increased lung uptake of thallium-201 during exercise myocardial imaging: Clinical, hemodynamic and angiographic implications in patients with coronary artery disease. Am J Cardiol 1980; 46: 189-196.
2. Bingham J, McKusick K, Strauss H, Boucher C, Pohest G. Influence of coronary artery disease on pulmonary uptake of thallium-201. Am J Cardiol 1980; 46: 821-826.
3. Kushner F, Okada R, Kirchenbaum H, Boucher C, Strauss H, Pohest G. Lung thallium uptake after stress testing in patients with coronary artery disease. Circulation 1981; 63: 342-347.
4. Wilson R, Okada R, Boucher C, Strauss H, Pohest G. Radionuclide determined changes in pulmonary blood volume and thallium uptake in patients with coronary artery disease. Am J Cardiol 1983; 51: 741-748.
5. Homma S, Kaul S, Boucher C. Correlates of lung/heart ratio of thallium-201 in coronary artery disease. J Nucl Med 1987; 28: 1531-1535.
6. Gill J, Ruddy T, Newell J, Finkelstein D, Strauss H, Boucher C. Prognostic importance of thallium uptake by lungs during exercise in coronary artery disease. N Engl J Med 1987; 317: 1485-1489.
7. Gibson R, Watson D, Carabello B, Holt N, Beller G. Clinical implications of increased lung uptake of thallium-201 during exercise scintigraphy 2 weeks after myocardial infarction. Am J Cardiol 1982; 49: 1586-1593.
8. Tamaki N, Itoh H, Ishii Y et al. Hemodynamic significance of increased lung uptake of thallium-201. Am J Radiol 1982; 138: 223-228.
9. Vaccarino R, Johnson L, Antunes M et al. Thallium-201 lung uptake and peak treadmill exercise first-pass ejection fraction. Am Heart J 1995; 129: 320-329.
10. Aksut S, Mallavarapu C, Russell J, Heo J, Iskandrian A. Implication of increased lung thallium uptake during exercise single photon emission computed tomography imaging. Am Heart J 1995; 130: 367-373.
11. Palmas W, Bingham S, Diamond G et al. Incremental prognostic value of exercise thallium-201 myocardial singlephoton emission computed tomography late after coronary artery bypass surgery. J Am Coll Cardiol 1995; 25: 403-409.
12. Guibbini R, Campini R, Milan E et al. Evaluation of techne-tium-99m-sestamibi lung uptake: Correlation with left ventricular function. J Nucl Med 1995; 36: 58-63.
13. Hurwitz G, Fox S, Diredger A, Willems C, Powe J. Pulmonary uptake of sestamibi on early post-stress images: Angiographic relationships, incidence and kinetics. Nucl Med Commun 1993; 14: 15-22.
14. Ilmer B, Reijs A, Fioretti P, Reiber J. Comparative study of three different approaches to the estimation of the lung-heart ratio in thallium 201 scintigrams in relation to the extent of coronary artery disease and left ventricular function. Eur J Nucl Med 1991; 18: 252-258.
15. Kurata C, Tawarahara K, Taguchi T, Sakata K, Yamazaki N, Naitoh Y. Lung thallium-201 uptake during exercise emission computed tomography. J Nucl Med 1991; 32: 417-423.
16. Nishimura S, Mahmarian JJ, Verani MA. Significance of increased lung thallium uptake during adenosine thallium-201 scintigraphy. J Nucl Med 1992; 33: 1600-1607.
17. Kahn J, Carry M, McGhie I, Pippin J, Akers M, Corbett J. Quantitation of post-exercise lung thallium-201 uptake during single photon emission computed tomography. J Nucl Med 1989; 30: 288-294.
18. Heo J, Cave V, Wasserleben V, Iskandrian A. Planar and tomographic imaging with technetium 99m-labeled tetro-fosmin: Correlation with thallium-201 and coronary angiography. J Nucl Cardiol 1994; 1: 17-24.
19. Rembold C, Watson D. Posttest probability calculation weights: A simple form of Bayes’ theorem. Am Intern Med 1988; 108: 115-120.
20. Heiba SI, Hayat NJ, Slaman HS et al. Technetium-99m MIBI myocardial SPECT: Supine versus right lateral imaging and comparison with coronary arteriography. J Nucl Med 1997; 38: 1510-1514.
21. Higley B, Smith F, Gemmell H et al. Technetium-99m-1,2-bis[bis(2-ethoxyethyl)phosphino]ethane: Human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993; 34: 30-38.
22. Nakajima K, Taki J, Shuke N, Bunko H, Takata S, Hisada K. Myocardial perfusion imaging and dynamic analysis with technetium-99m tetrofosmin. J Nucl Med 1993; 34: 1478-1484.
23. Jain D, Wakers F, Mattera J, McMahon M, Sinusas A, Zaret B. Biokinetics of technetium-99m-tetrofosmin: Myocardial perfusion imaging agent. Implication for one-day imaging protocol. J Nucl Med 1993; 34: 1254-1259.
24. Thorley P, Ball J, Sheard K, Sivananthan U. Evaluation of Tc-99m tetrofosmin as a myocardial perfusion agent in routine clinical use. Nucl Med Commun 1995; 16: 733-740.
25. Zaret B, Rigo P, Wakers F et al. Myocardial perfusion imaging with Tc-99m tetrofosmin: Comparison to Tl-201 imaging and coronary angiography in a phase III multicentric trial. Circulation 1995; 91: 313-319.
26. Rigo P, Leclercq B, Itti R, Lahiri A, Braat S. Technetium-99m-tetrofosmin myocardial imaging: A comparison with thallium-201 and angiography. J Nucl Med 1994; 35: 587-593.
27. Tamaki N, Takahashi N, Kawamoto M et al. Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease. J Nucl Med 1994; 35: 594-600.
28. Cuocolo A, Soricelli A, Nicolae E et al. Technetium-99m-tetrofosmin regional myocardial uptake at rest: Relation to severity of coronary artery stenosis in previous myocardial infarction. J Nucl Med 1995; 36: 907-913.
29. Flamen P, Bossuyt A, Franken P. Technetium-99m-tetrofos-min in dipyridamole-stress myocardial SPECT irrfaging: Intraindividual comparison with technetium-99m-sesta-mibi. J Nucl Med 1995; 36: 2009-2015.